UiPath (NYSE:PATH) Posts Earnings Results, Beats Estimates By $0.01 EPS

UiPath (NYSE:PATH) announced its earnings results on Thursday. The healthcare company reported $0.04 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.01, Briefing.com reports. UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The business had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. During the same period in the prior year, the firm earned ($0.09) earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. UiPath updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

UiPath Price Performance

NYSE:PATH opened at $11.98 on Friday. The firm has a market capitalization of $6.86 billion, a P/E ratio of -74.84 and a beta of 0.87. The business has a 50 day simple moving average of $12.20 and a 200 day simple moving average of $16.71. UiPath has a 12-month low of $10.37 and a 12-month high of $27.87.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. DA Davidson upped their price objective on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Friday. KeyCorp restated a “sector weight” rating on shares of UiPath in a research note on Thursday, May 30th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $16.00 target price on shares of UiPath in a research report on Friday. BMO Capital Markets increased their target price on UiPath from $14.00 to $15.00 and gave the company a “market perform” rating in a research note on Friday. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $15.00 price target on shares of UiPath in a report on Friday. Sixteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $17.71.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.